Acquisition of EUROPHARMA by UNIVERSAL MEDICA GROUP
Universal Medica Group (UMG) has taken yet another step forward in its development by acquiring the company EUROPHARMA, an expert in medical training and a pioneer in E-learning within the pharmaceutical industry. This brand new acquisition fits perfectly into the EU’s ‘Horizon 2020’ strategic framework – to boost the added value of innovative services, those […]
Meet us at DIA Euromeeting 2017!
We are pleased to announce that we will be hosting at the upcoming DIA EuroMeeting in Glasgow! We invite you to come & meet our team and discover our digital solutions dedicated to Life Sciences! You can find our team at stand number E6. Why meet Universal Medica? Thanks to the quality of our processes […]
The early bird of Innovation Days 2015 is coming to an end!
Only a few days left to take advantage of the preferential rate for registration for Innovation Days 2015, which will be held on 5 and 6 October at the Cité Universitaire de Paris. Strategic alliances, open innovation and e-health are on the agenda this year, with interactive conferences led by experts. This is also the […]
Read the interview with Rafi Mardachti, Chairman of Universal Medica Group, in l’Expansion
Rafi Mardachti, Chairman of Universal Medica Group and Universal Biotech was contacted by the magazine l’Expansion for its special report on “Research and Biotechnology”. A company at the heart of the changes in the life sciences field, Universal Biotech organises the Innovation Prize every year. The magazine’s journalist and Rafi Mardachti talked about the selection […]
Meet Universal Medica at DIA Euromeeting 2015 – April 13, 14 &15 2015
This year, Universal Medica is attending to the 27 th DIA Annual Euromeeting on 13 to 15 april 2015. What is DIA 2015? DIA Euromeeting is the opportunity to reach the full range of medicines development professionnals. From pharmaceuticals and biotech industry to CROs, regulators froms EMA, FDA and euopean countries national regulatory agencies and […]
Less than 3 weeks before the opening of the call for proposal!
Innovation Prize: What? For the 7th consecutive year, Universal Biotech launches the Innovation Prize rewarding young starts-up and academic research groups in the field of Life Sciences. With the support of public organizations, pharmaceutical laboratories and biotechnology companies, the Innovation Prize aims to promote innovation in the healthcare industry. You will be able to submit […]
Universal Medica Group wishes you a very happy 2015!
The entire Universal Medica team wishes you a very happy new year, full of joy and happiness. 2014 was a year full of challenges, we look forward to cooperating with you again to face the ones 2015 has in store! Click on the cherry to find out more about our new activities
The ANSM is suspending 25 generic drugs marketed in France.
The ANSM is initiating a suspension procedure, as of December 18, of 25 drugs marketed in France. An inspection by the ANSM of a site of the company GVK Bio, which carries out clinical trials including bioequivalence trials in India, has revealed irregularities in documents associated with these trials on which the MA (marketing authorisation) […]
2014 Innovation Award winner signs $25 million development deal with Pfizer
Dear all, We are pleased to announce that one of the 5 finalists of the 2014 Innovation Prize has entered into a $25 million development agreement with pharmaceutical company Pfizer. In fact, Belgian company iTeos Therapeutics, led by Michel Detheux, is developing drug candidates that target Indoleamine-2,3-Dioxygenase (IDO1) and Tryptophan-2,3-Dioxygenase (TDO2). This news highlights the […]
Be part of the jury of the Innovation Award 2015
Open to young innovative start-ups as well as public and private research laboratories, the Universal Biotech Innovation Award aims to highlight at a global level the most innovative projects in the field of Life Sciences: Biotech, Medtech, e-Health. Today we are offering you the opportunity to join this event dedicated to innovation in the field […]
